Synapse

← Oncology and Translational Medicine

Papers in Oncology and Translational Medicine

Page 1 · newest first

  1. Expert consensus on Laennec capsule–guided hepatobiliary surgery (2026 Edition)Oncology and Translational Medicine · 2026
  2. Advances in BCL6-targeted cancer therapy: From functional inhibition to PROTAC degradationOncology and Translational Medicine · 2026
  3. Cardiac allograft vasculopathy: A comprehensive review of diagnostic strategies and therapeutic approachesOncology and Translational Medicine · 2026
  4. Clinical significance of HER2-low expression in early breast cancer: A single-center experienceOncology and Translational Medicine · 2026
  5. Tiered quality control in urine-derived iPSC reprogramming determines pan-cancer modeling reliabilityOncology and Translational Medicine · 2026
  6. Nanoparticle-based precision modeling of primary and three-dimensional cell culture in cancer theranosticsOncology and Translational Medicine · 2026
  7. Antecedent behaviors related to cervical cancer prevention and screening among female staff in a Nigerian universityOncology and Translational Medicine · 2026
  8. Safety assessment for hepatectomy in patients with hepatocellular carcinoma combined with hepatitis B-related cirrhosis: Expert consensusOncology and Translational Medicine · 2026
  9. Incidence of pembrolizumab-induced diabetes mellitus in nonsmall cell lung cancer: A systematic review and meta-analysisOncology and Translational Medicine · 2026
  10. Next-Gen immunotherapy inhematological malignancies: A systematic review and meta-analysis oftranslational breakthroughs, regulatory milestones, and clinical trial trajectories (2018–2025)Oncology and Translational Medicine · 2026
  11. Pan-cancer analysis combined with single-cell profiling reveals epigenetic and immune associations of ADH4 in hepatocellular carcinomaOncology and Translational Medicine · 2026
  12. SNRPB drives pan-cancer tumorigenesis and immunotherapy resistance via immune microenvironment remodelingOncology and Translational Medicine · 2026
  13. Adoption of the distal transradial approach in percutaneous coronary intervention: A contemporary reviewOncology and Translational Medicine · 2026
  14. Cardiac Arrhythmias in Heart Transplant RecipientsOncology and Translational Medicine · 2026
  15. A systematic review and time-specific meta-analysis of hepatocellular carcinoma risk prediction modelsOncology and Translational Medicine · 2026
  16. Divergent drivers of the myelodysplastic syndrome, myeloproliferative neoplasm, and myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes burden: Pronounced role of population aging in China compared with global trends (1990–2021)Oncology and Translational Medicine · 2026
  17. Decoding microRNAs as potential biomarkers and therapeutic targets in head and neck cancerOncology and Translational Medicine · 2026
  18. The role of PCSK9 in cancer risk: Population-level evidence and mechanistic insightsOncology and Translational Medicine · 2026
  19. Exploring the YANK family: Emerging therapeutic targets for various diseasesOncology and Translational Medicine · 2026
  20. From bench to bedside: The evolving role of focused ultrasound in managing Parkinson’s diseaseOncology and Translational Medicine · 2026
  21. The roles of cGAS-STING pathway in cancerOncology and Translational Medicine · 2026
  22. Tracing the evolution and progression of bladder cancer from epigenetic origins to clinical early diagnosticsOncology and Translational Medicine · 2026
  23. Feasibility study on microwave ablation of liver tumor via the inferior vena cava approachOncology and Translational Medicine · 2026
  24. IGSF8 (CD316) defines a distinct transcriptional phenotype independent of immune infiltration in lung adenocarcinoma: An integrative immunogenomic analysisOncology and Translational Medicine · 2026
  25. Unveiling the implications of GALNT2, a key glycosylation enzyme, in pan-cancer: A comprehensive multidatabase studyOncology and Translational Medicine · 2026
  26. Medicinal plants with antineoplastic potency and possible biomarkers for monitoring and diagnosing neoplastic diseaseOncology and Translational Medicine · 2026
  27. Patients with arrhythmogenic left ventricular cardiomyopathy who underwent heart transplantation: A case studyOncology and Translational Medicine · 2026
  28. Epithelial-mesenchymal transition, stemness, and carcinosarcoma generationOncology and Translational Medicine · 2026
  29. Helicobacter pylori and miR-136: Key players in gastric cancer research (mini review)Oncology and Translational Medicine · 2026
  30. Development of pancreatic surgery in ChinaOncology and Translational Medicine · 2025
  31. Expert consensus on the selection of surgical treatment modalities for hepatocellular carcinoma (fourth revision)Oncology and Translational Medicine · 2026
  32. Expert consensus on the management of thrombocytopenia in patients undergoing surgery for digestive system neoplasmsOncology and Translational Medicine · 2026
  33. Global, regional, and national lung cancer burden attributable to low fruit intake: 2021 Global Burden of Disease Study AnalysisOncology and Translational Medicine · 2026
  34. Albumin-to-globulin ratio as a prognostic indicator in elderly patients with esophageal squamous cell carcinoma undergoing radical radiotherapyOncology and Translational Medicine · 2026
  35. Key points for the Chen's transpancreatic continuous U-suture technique for pancreaticojejunostomyOncology and Translational Medicine · 2026
  36. Immune checkpoint blockade in glioblastoma: overcoming barriers through mechanism-informed, biomarker-guided, and combinatorial immunotherapies targeting the tumor microenvironment and validated by clinical trialsOncology and Translational Medicine · 2025
  37. Expert consensus on multidisciplinary collaboration in perioperative immunotherapy for hepatocellular carcinoma (2025 edition)Oncology and Translational Medicine · 2025
  38. Expert consensus on multidisciplinary collaboration in perioperative immunotherapy for hepatocellular carcinoma (2025 edition)Oncology and Translational Medicine · 2025
  39. Repurposing carbamazepine in oncology and rare genetic diseases: A clinical updateOncology and Translational Medicine · 2025
  40. Repurposing carbamazepine in oncology and rare genetic diseases: A clinical updateOncology and Translational Medicine · 2025
  41. Comprehensive analysis of CDC20 as a prognostic biomarker in lung adenocarcinomaOncology and Translational Medicine · 2025
  42. Current status and future prospects of interventional radiology in ChinaOncology and Translational Medicine · 2025
  43. Hepatoprotective effect of acetaminophen against diethylnitrosamine-induced hepatocellular carcinoma in ratsOncology and Translational Medicine · 2025
  44. Controversy and progress in surgical treatment of hilar cholangiocarcinomaOncology and Translational Medicine · 2025
  45. Bioinformatics analysis of the association between hsa-miR-101-3p–induced downregulation of PIEZO1 and poor prognosis in head and neck squamous cell carcinoma mediated by the focal adhesion pathwayOncology and Translational Medicine · 2025
  46. Watch-and-wait strategy for complete responders after conversion therapy for initially unresectable hepatocellular carcinomaOncology and Translational Medicine · 2025
  47. Regulation of gene expression by FOXA1Oncology and Translational Medicine · 2025
  48. Chylothorax and 10-year chronicity after Sprycel (dasatinib) treatment for chronic myelogenous leukemia: A case report and reviewOncology and Translational Medicine · 2025
  49. Enhancing chemosensitivity in pancreatic cancer: novel strategies to overcome therapeutic resistanceOncology and Translational Medicine · 2025
  50. Constructing datasets and training deep networks for the direct apoptotic cell identification from H&E staining imagesOncology and Translational Medicine · 2025